B-type natriuretic peptide: biomarker of persistent pulmonary hypertension of the newborn?

Abstract

OBJECTIVE We assessed the utility of plasma B-type natriuretic peptide (BNP) in infants with persistent pulmonary hypertension of the newborn (PPHN) in the prediction of inhaled nitric oxide (iNO) requirement. METHODS This prospective study involved neonates (gestational age ≥ 34 weeks) with PPHN and confirmatory echocardiographic findings. Plasma BNP was… (More)
DOI: 10.1055/s-0035-1548540

5 Figures and Tables

Topics

  • Presentations referencing similar topics